Human TNF alpha Monoclonal Antibody
Product Sizes
1 mg
£268.00
YR0014-1MG
5 mg
£746.00
YR0014-5MG
20 mg
£1442.00
YR0014-20MG
About this Product
- SKU:
- YR0014
- Additional Names:
- DIF|TNF|TNFA|TNFSF2|TNLG1F
- Application:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Clonality:
- Monoclonal
- Extra Details:
- Infliximab, a chimeric anti-TNF-A Alpha monoclonal antibody, is used to treat psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Infliximab interferes TNF-A Alpha from binding to its receptor in the cell.Mainly produced by activated macrophages (M1), Tumor necrosis factor (TNF, cachexin, cachectin, tumor necrosis factor alpha, TNFA Alpha) plays important roles in the regulation of autoimmune reaction.
- Formulation:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human TNF alpha
- Isotype:
- IgG1, kappa
- Molecular Weight:
- 150 kDa
- Purity:
- >95%
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- ABclonal Technology
- Type:
- Antibody: Biosimilar Antibody
- Manufacturer's Data Sheet:YR0014
